EXAS vs EYE · rev $2.76B vs rev $437.3M
EXACT Sciences Corporation (EXAS) versus National Vision Holdings Inc (EYE) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
National Vision Holdings Inc (EYE) is a specialty retail company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported EYE revenue for 2024-12-28 was $437.3M. Net income was -$28.6M. Revenue was down 3.2% from 2024-09-28 to 2024-12-28. EYE currently screens at market cap $1.93B.
EXAS currently screens at market cap $20.03B. EYE currently screens at market cap $1.93B.
Not investment advice. Open the EXAS and EYE stock pages for the full models.
Not investment advice.